Previous studies showed the IL-9 level elevation in several dermatological diseases, including atopic dermatitis, psoriasis vulgaris, and cutaneous T-cell lymphoma (17). This evidence concerns the gene IL9 and primary cutaneous T-cell non-Hodgkin lymphoma.